Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,612,794
+$304,555 QoQ
Shares Held
14,357
-5.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.17%
of 13F equity value
Holder Rank
#1,524
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesapeake Wealth Management holds $12,931,041 across 7 Drug Manufacturers - General names. ABBV ranks #2 (27.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,031 | $3,635,471 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
14,357 | $3,612,794 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,024 | $1,930,584 | |
| 4 | JNJ |
Johnson & Johnson
|
7,575 | $1,923,822 | |
| 5 | AMGN |
Amgen Inc
|
3,188 | $1,154,437 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,265 | $360,989 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,477 | $312,944 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,612,794 | 14,357 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,308,239 | 15,211 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $3,435,346 | 15,035 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,407,805 | 14,718 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,675,340 | 14,413 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,877,337 | 13,733 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,515,698 | 14,157 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $2,867,803 | 14,522 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,501,104 | 14,582 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,696,718 | 14,809 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,318,350 | 14,960 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,254,233 | 15,123 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $2,060,964 | 15,297 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $2,292,058 | 14,382 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,114,343 | 13,083 | Shares | Sole | 2023-02-23 | |
| 2022-09-30 | $1,446,514 | 10,778 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $1,633,144 | 10,663 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,748,355 | 10,785 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,540,174 | 11,375 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,256,900 | 11,652 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,384,908 | 12,295 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,414,650 | 13,072 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,437,094 | 13,412 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $1,215,660 | 13,879 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,361,068 | 13,863 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,010,279 | 13,260 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||